SCI offers Innovation Awards to support collaborative projects focused on acceleration of basic, translational, clinical and population-based cancer research, and projects focused on cancer care, such as pancreatic, breast and gynecologic cancers.
The Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation and Clinical Impact is offering a Fall 2023 Seed Grant to support researchers and scientists in advancing specific domains of maternal-fetal science.
Stanford University’s Innovative Medicines Accelerator (IMA) is accepting proposals for projects that use a recent advance in human organ modeling to address the IMA’s goals of accelerating the prototyping of innovative medicines and vaccines.
DUE: October 2nd The Neuroscience:Translate program supports translational research addressing unmet needs in any area of neuroscience. Resulting technologies & therapies are intended to lead to licensing exits to eventually reach the patient.
SCI’s mission is to translate Stanford discoveries into individualized cancer care and prevention. In keeping with its goal of educating and empowering the next generation of cancer researchers, SCI offers funding to cancer research fellows.
To support biomedical research in diabetes, the Stanford Diabetes Research Center (SDRC) invites applications for the 2023-24 Pilot and Feasibility (P&F) Program led by Drs. Anna Gloyn and Sun H Kim.
The Center for Artificial Intelligence in Medicine and Imaging (AIMI) and the Institute for Human-Centered Artificial Intelligence (HAI) jointly seek proposals that support new ideas that reimagine artificial intelligence in healthcare.
The goal of the Institute for Human-Centered Artificial Intelligence research program is to foster interdisciplinary AI research that aims to improve the human condition. We seek proposals for up to $75,000 that support new ambitious ideas.
